European Companies Search Engine

EU funding (€10.9M): Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes Hor12 Dec 2024 EU Research and Innovation programme "Horizon"

Text

Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes

DORIAN GRAY project investigates the link between cardiovascular disease (CVD) and Mild Cognitive Impairment (MCI) in the ageing population. Its goal is to uncover underlying mechanisms to promote healthy, independent, and active living while reducing disease burden. Aligned with Horizon Europe’s Strategic Plan on NCDs prevention, the project focuses on two core objectives: designing a multidomain intervention to delay CVD-related MCI progression and developing digital solutions to enhance its adherence. By leveraging large datasets that include omics, brain imaging, lifestyle behaviors, and socio-economic data, the project aims to develop a trustworthy AI tool for predicting MCI. The AI tool will be upgraded into a state-of-the-art framework for modelling and simulation (digital twin), integrating real-world data collected in clinical studies from smartwatches and mobile devices. Including these digital biomarkers enable the early detection of disease and enhance precision in healthcare. The DIGITAL TWIN will inform and update a personalized multidomain intervention using a novel avatar-based coaching exergame, which will serve dual purposes: as a cognitive enhancement tool with structured physical-cognitive tasks and as a lifestyle intervention promoting positive behaviours experienced in the virtual environment. Feasibility will be tested in a pilot randomized controlled trials involving patients with MCI and heart failure, and in an implementation study with patients having MCI and cardiovascular risk factors. To achieve his aim DORIAN GRAY brings together a diverse team of experts, including clinicians, psychologists, sports scientists, computers engineers, AI specialists, stakeholders, entrepreneurs, and academics in ethics, law, and theoretical philosophy. Patients and citizens actively engage in shaping and guiding project decisions. DORIAN GRAY is projected to prevent up to 2 million dementia cases over 27 years, leading to a cost reduction of 485 billion.


Funded Companies:

Company name Funding amount
HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE ?
Alzheimer Europe €234,219
CHARITE - UNIVERSITAETSMEDIZIN BERLIN €1,143,925
Fakultni Nemocnice U SV Anny V Brne €147,233
Fondation Optalmologique Adolphe de Rothschild €500,042
I2Grow Innovation TO Grow Srl €148,503
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI €149,996
Idryma Technologias Kai Erevnas €840,500
Infotrend Innovations Company Ltd. €282,384
Institutul de Urgenta Pentru Boli Carvasculare Prof DR CC Iliescu €146,875
Krajska Nemocnice Liberec a.s. €345,175
Lifescience Innovation Good Healthcare Technology S.C.A R.L. €0.00
Moverim Srl €220,750
NUROGAMES GmbH €301,425
Politecnico Di Milano €498,750
Ropardo Srl €209,500
SE de Cardiologie €299,989
The Chancellor Masters and Scholars of the University of Cambridge €310,094
The University of Liverpool €1,467,577
Universita Degli Studi Di Brescia €2,387,504
Universita Degli Studi Di Roma LA Sapienza €158,625
UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT €209,895
UNIVERSITEIT MAASTRICHT €249,200
University Hospitals Coventry and Warwickshire National Health Service Trust €269,266
Univerzita Hradec Kralove €399,688

Source: https://cordis.europa.eu/project/id/101156266

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Haute Ecole Specialisee DE Suisse Occidentale, Delémont, Switzerland.

Creative Commons License The visualizations for "HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE - EU funding (€10.9M): Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.